170 related articles for article (PubMed ID: 27495099)
1. Comparison between whole mount tissue preparations and virtual tissue microarray samples for measuring Ki-67 and apoptosis indices in human bladder cancer: A cross-sectional study.
Oshiro H; Czerniak BA; Sakamaki K; Tsuta K; Bondaruk J; Keyhani A; Dinney CP; Nagai T; Kamat AM
Medicine (Baltimore); 2016 Aug; 95(31):e4500. PubMed ID: 27495099
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of ki-67 in breast carcinoma: tissue microarray method versus whole section analysis- potentials and pitfalls.
Dedić Plavetić N; Jakić-Razumović J; Kulić A; Sirotković-Skerlev M; Barić M; Vrbanec D
Pathol Oncol Res; 2015 Apr; 21(2):315-24. PubMed ID: 25096394
[TBL] [Abstract][Full Text] [Related]
3. [The detection of protein expression of clusterin and Ki-67 and the status of cell apoptosis in bladder transitional cell carcinoma].
Chen W; Xie D; Luo JH; Wang CX; Tao Y; Zheng KL; Mei H
Zhonghua Wai Ke Za Zhi; 2006 Jan; 44(2):111-4. PubMed ID: 16620672
[TBL] [Abstract][Full Text] [Related]
4. Ki67 expression in invasive breast cancer: the use of tissue microarrays compared with whole tissue sections.
Muftah AA; Aleskandarany MA; Al-Kaabi MM; Sonbul SN; Diez-Rodriguez M; Nolan CC; Caldas C; Ellis IO; Rakha EA; Green AR
Breast Cancer Res Treat; 2017 Jul; 164(2):341-348. PubMed ID: 28478613
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of Ki-67, p21waf1/cip1 and apoptosis in marker lesions from patients with superficial bladder tumours treated with vinorelbine intravesical therapy in a preliminary phase I trial.
Bonfil RD; Gonzalez AD; Siguelboim D; Cuello Carrion FD; Ciocca DR; Villaronga A; Metz L; Mosso F; Fayad E; Reale M; Schmilovich AJ
BJU Int; 2001 Sep; 88(4):425-31. PubMed ID: 11564034
[TBL] [Abstract][Full Text] [Related]
6. Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade.
Nocito A; Bubendorf L; Tinner EM; Süess K; Wagner U; Forster T; Kononen J; Fijan A; Bruderer J; Schmid U; Ackermann D; Maurer R; Alund G; Knönagel H; Rist M; Anabitarte M; Hering F; Hardmeier T; Schoenenberger AJ; Flury R; Jäger P; Fehr JL; Schraml P; Moch H; Mihatsch MJ; Gasser T; Sauter G
J Pathol; 2001 Jul; 194(3):349-57. PubMed ID: 11439368
[TBL] [Abstract][Full Text] [Related]
7. Tissue microarray studies in bladder cancer.
Hartmann A
Scand J Urol Nephrol Suppl; 2008 Sep; (218):141-6. PubMed ID: 18815928
[TBL] [Abstract][Full Text] [Related]
8. Tissue microarray is suitable for scientific biomarkers studies in endometrial cancer.
Visser NCM; van der Wurff AAM; Pijnenborg JMA; Massuger LFAG; Bulten J; Nagtegaal ID
Virchows Arch; 2018 Mar; 472(3):407-413. PubMed ID: 29426961
[TBL] [Abstract][Full Text] [Related]
9. Virtual tissue microarrays: a novel and viable approach to optimizing tissue microarrays for biomarker research applied to ductal carcinoma in situ.
Quintayo MA; Starczynski J; Yan FJ; Wedad H; Nofech-Mozes S; Rakovitch E; Bartlett JM
Histopathology; 2014 Jul; 65(1):2-8. PubMed ID: 24267587
[TBL] [Abstract][Full Text] [Related]
10. Comparison of TMA Technique and Routine Whole Slide Analysis in Evaluation of Proliferative Markers Expression in Laryngeal Squamous Cell Cancer.
Ciesielska U; Piotrowska A; Kobierzycki C; Pastuszewski W; Podhorska-Okolow M; Dziegiel P; Nowinska K
In Vivo; 2020; 34(6):3263-3270. PubMed ID: 33144432
[TBL] [Abstract][Full Text] [Related]
11. Bcl-2 predicts response to neoadjuvant chemotherapy and is overexpressed in lymph node metastases of urothelial cancer of the bladder.
Kiss B; Skuginna V; Fleischmann A; Bell RH; Collins C; Thalmann GN; Seiler R
Urol Oncol; 2015 Apr; 33(4):166.e1-8. PubMed ID: 25596645
[TBL] [Abstract][Full Text] [Related]
12. Larger core size has superior technical and analytical accuracy in bladder tissue microarray.
Eskaros AR; Egloff SA; Boyd KL; Richardson JE; Hyndman ME; Zijlstra A
Lab Invest; 2017 Mar; 97(3):335-342. PubMed ID: 28112755
[TBL] [Abstract][Full Text] [Related]
13. [The value of Ki-67 antigen expression in tissue microarray method in prediction prognosis of patients with endometrioid endometrial cancer].
Gottwald L; Kubiak R; Sek P; Piekarski J; Szwalski J; Pasz-Walczak G; Spych M; Suzin J; Tylińskis W; Jeziorski A
Ginekol Pol; 2013 Jun; 84(6):444-9. PubMed ID: 24032262
[TBL] [Abstract][Full Text] [Related]
14. Correlation of mitotic indices, AgNor count, Ki-67 and Bcl-2 with grade and stage in papillary urothelial bladder cancer.
Goyal S; Singh UR; Sharma S; Kaur N
Urol J; 2014 Mar; 11(1):1238-47. PubMed ID: 24595931
[TBL] [Abstract][Full Text] [Related]
15. Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer.
Bertz S; Otto W; Denzinger S; Wieland WF; Burger M; Stöhr R; Link S; Hofstädter F; Hartmann A
Eur Urol; 2014 Jan; 65(1):218-26. PubMed ID: 22633802
[TBL] [Abstract][Full Text] [Related]
16. Extent, impact, and mitigation of batch effects in tumor biomarker studies using tissue microarrays.
Stopsack KH; Tyekucheva S; Wang M; Gerke TA; Vaselkiv JB; Penney KL; Kantoff PW; Finn SP; Fiorentino M; Loda M; Lotan TL; Parmigiani G; Mucci LA
Elife; 2021 Dec; 10():. PubMed ID: 34939926
[TBL] [Abstract][Full Text] [Related]
17. Digital pathology for the validation of tissue microarrays in peripheral T-cell lymphomas.
Pedersen MB; Riber-Hansen R; Nielsen PS; Bendix K; Hamilton-Dutoit SJ; D'Amore F; Steiniche T
Appl Immunohistochem Mol Morphol; 2014 Sep; 22(8):577-84. PubMed ID: 24897068
[TBL] [Abstract][Full Text] [Related]
18. Influence of intra-tumoral heterogeneity on the evaluation of BCL2, E-cadherin, EGFR, EMMPRIN, and Ki-67 expression in tissue microarrays from breast cancer.
Tramm T; Kyndi M; Sørensen FB; Overgaard J; Alsner J
Acta Oncol; 2018 Jan; 57(1):102-106. PubMed ID: 29202620
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
Shariat SF; Bolenz C; Godoy G; Fradet Y; Ashfaq R; Karakiewicz PI; Isbarn H; Jeldres C; Rigaud J; Sagalowsky AI; Lotan Y
J Urol; 2009 Jul; 182(1):78-84; discussion 84. PubMed ID: 19447418
[TBL] [Abstract][Full Text] [Related]
20. Association of cyclin D1 and E1 expression with disease progression and biomarkers in patients with nonmuscle-invasive urothelial cell carcinoma of the bladder.
Shariat SF; Ashfaq R; Sagalowsky AI; Lotan Y
Urol Oncol; 2007; 25(6):468-75. PubMed ID: 18047954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
